Horizon Bancorp’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
VCM
VPM
Horizon Bancorp's BIIB Position: Q1 2026 in Review
Horizon Bancorp increased its Biogen (BIIB) stake by 3.6% in Q1 2026, buying an estimated $6.45K and bringing the position to 1,017 shares worth $186K. The position accounts for 0.09% of the portfolio, ranked #81.
Horizon Bancorp first reported a position in BIIB in Q3 2020 and has held it in 14 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Horizon Bancorp held 1,017 shares of Biogen worth $186K as of Q1 2026.
- Horizon Bancorp bought 35 Biogen shares in Q1 2026, an estimated $6.45K.
- Biogen made up 0.09% of Horizon Bancorp's portfolio in Q1 2026, its #81 holding.
- Horizon Bancorp first reported a position in Biogen in Q3 2020 and has held it in 14 quarters since.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Horizon Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.